PE20071089A1 - Compuesto heterociclico fusionado como inhibidor de tirosina quinasa - Google Patents
Compuesto heterociclico fusionado como inhibidor de tirosina quinasaInfo
- Publication number
- PE20071089A1 PE20071089A1 PE2006001541A PE2006001541A PE20071089A1 PE 20071089 A1 PE20071089 A1 PE 20071089A1 PE 2006001541 A PE2006001541 A PE 2006001541A PE 2006001541 A PE2006001541 A PE 2006001541A PE 20071089 A1 PE20071089 A1 PE 20071089A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- tyrosine kinase
- heterocyclic compound
- fused heterocyclic
- chlorophenoxy
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title abstract 2
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 title 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title 1
- 150000004917 tyrosine kinase inhibitor derivatives Chemical class 0.000 title 1
- -1 3-CHLOROPHENOXY Chemical class 0.000 abstract 3
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 3
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 3
- 150000002367 halogens Chemical class 0.000 abstract 3
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 2
- LKJPYSCBVHEWIU-UHFFFAOYSA-N N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide Chemical compound C=1C=C(C#N)C(C(F)(F)F)=CC=1NC(=O)C(O)(C)CS(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
SE REFIERE A UN COMPUESTO HETEROCICLICO FUSIONADO DE FORMULA (Ia), EN DONDE R1a ES H; R2a ES ALQUILO(C1-C6) SUSTITUIDO CON ALQUILO (C1-C4) OPCIONALMENTE HALOGENADO CON -NR6a-CO-(CH2)n-SO2-; R3a ES H O ALQUILO(C1-C6); R4a ES HALOGENO O ALQUILO(C1-C6); R5a ES HALOGENO O ALQUILO(C1-C6); Xa ES H O HALOGENO CON LA CONDICION DE QUE SE EXCLUYA N-[2-(4-{[3-CLORO-4-(3-CLOROFENOXI)FENIL]AMINO}-5H-PIRROLO[3,2-d]PIRIMIDIN-5-IL)ETIL]-2-(METILSULFONIL)ACETAMIDA. SON SELECCIONADOS: N-[2-(4-{[3-CLORO-4-(3-CLOROFENOXI)FENIL]AMINO}-5H-PIRROLO[3,2-d]PIRIMIDIN-5-IL)ETIL]-2-METIL-2-(METILSULFONIL)PROPANAMIDA, N-[2-(4-{[3-CLORO-4-(3-CLOROFENOXI)FENIL]AMINO}-5H-PIRROLO[3,2-d]PIRIMIDIN-5-IL)ETIL]-2-(ETILSULFONIL)ACETAMIDA, ENTRE OTROS. TAMBIEN SE REFIERE A UNA COMPOSICION FARMACEUTICA Y UN PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON INHIBIDORES DE LA TIROSINA QUINASA Y SON UTILES EN EL TRATAMIENTO DE CANCER
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005349858 | 2005-12-02 | ||
| JP2006060648 | 2006-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20071089A1 true PE20071089A1 (es) | 2007-11-19 |
Family
ID=37897379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006001541A PE20071089A1 (es) | 2005-12-02 | 2006-12-01 | Compuesto heterociclico fusionado como inhibidor de tirosina quinasa |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20100216788A1 (es) |
| EP (1) | EP1957495A1 (es) |
| JP (1) | JP2009517333A (es) |
| KR (1) | KR20080084823A (es) |
| AR (1) | AR057961A1 (es) |
| AU (1) | AU2006319787A1 (es) |
| BR (1) | BRPI0619911A2 (es) |
| CA (1) | CA2631066A1 (es) |
| CR (1) | CR10057A (es) |
| MA (1) | MA30046B1 (es) |
| NO (1) | NO20082870L (es) |
| PE (1) | PE20071089A1 (es) |
| RU (1) | RU2008126949A (es) |
| TW (1) | TW200730527A (es) |
| WO (1) | WO2007064045A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06013996A (es) * | 2004-06-02 | 2007-02-08 | Takeda Pharmaceutical | Compuesto heterociclico fusionado. |
| EP2103620A1 (en) * | 2006-12-12 | 2009-09-23 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compound |
| US7825127B2 (en) | 2006-12-28 | 2010-11-02 | Takeda Pharmaceutical Company, Limited | Method for treating cancer |
| AU2008264469A1 (en) | 2007-06-19 | 2008-12-24 | Takeda Pharmaceutical Company Limited | Preventive/remedy for cancer |
| AR070735A1 (es) * | 2008-03-03 | 2010-04-28 | Takeda Pharmaceutical | Farmaco combinado para el tratamiento del cancer. |
| TW200944528A (en) * | 2008-03-12 | 2009-11-01 | Takeda Pharmaceutical | Fused heterocyclic compound |
| JP2014520151A (ja) | 2011-06-20 | 2014-08-21 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 蠕虫感染を処置するためのヘテロ環式化合物 |
| US9321750B2 (en) | 2012-04-20 | 2016-04-26 | Innov17 Llc | ROR modulators and their uses |
| SG11201600159TA (en) * | 2013-07-31 | 2016-02-26 | Merck Patent Gmbh | Pyridines, pyrimidines, and pyrazines, as btk inhibitors and uses thereof |
| GB201520499D0 (en) * | 2015-11-20 | 2016-01-06 | Medical Res Council Technology | Compounds |
| AR119494A1 (es) * | 2019-07-29 | 2021-12-22 | Servier Lab | DERIVADOS DE 6,7-DIHIDRO-5H-PIRIDO[2,3-c]PIRIDAZIN-8-ILO, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN Y SUS USOS COMO AGENTES PROAPOPTÓTICOS |
| WO2022221227A1 (en) | 2021-04-13 | 2022-10-20 | Nuvalent, Inc. | Amino-substituted heterocycles for treating cancers with egfr mutations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| UA71945C2 (en) * | 1999-01-27 | 2005-01-17 | Pfizer Prod Inc | Substituted bicyclic derivatives being used as anticancer agents |
| MXPA06013996A (es) * | 2004-06-02 | 2007-02-08 | Takeda Pharmaceutical | Compuesto heterociclico fusionado. |
| WO2006010264A1 (en) * | 2004-07-30 | 2006-02-02 | Methylgene, Inc. | Inhibitors of vegf receptor and hgf receptor signaling |
| TW200740820A (en) * | 2005-07-05 | 2007-11-01 | Takeda Pharmaceuticals Co | Fused heterocyclic derivatives and use thereof |
-
2006
- 2006-11-30 TW TW095144339A patent/TW200730527A/zh unknown
- 2006-12-01 WO PCT/JP2006/324499 patent/WO2007064045A1/en not_active Ceased
- 2006-12-01 PE PE2006001541A patent/PE20071089A1/es not_active Application Discontinuation
- 2006-12-01 EP EP06834254A patent/EP1957495A1/en not_active Withdrawn
- 2006-12-01 AU AU2006319787A patent/AU2006319787A1/en not_active Abandoned
- 2006-12-01 CA CA002631066A patent/CA2631066A1/en not_active Abandoned
- 2006-12-01 RU RU2008126949/04A patent/RU2008126949A/ru not_active Application Discontinuation
- 2006-12-01 US US12/095,543 patent/US20100216788A1/en not_active Abandoned
- 2006-12-01 JP JP2008520459A patent/JP2009517333A/ja not_active Withdrawn
- 2006-12-01 KR KR1020087016193A patent/KR20080084823A/ko not_active Withdrawn
- 2006-12-01 BR BRPI0619911A patent/BRPI0619911A2/pt not_active IP Right Cessation
- 2006-12-01 AR ARP060105330A patent/AR057961A1/es unknown
-
2008
- 2008-06-09 CR CR10057A patent/CR10057A/es not_active Application Discontinuation
- 2008-06-11 MA MA31024A patent/MA30046B1/fr unknown
- 2008-06-24 NO NO20082870A patent/NO20082870L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| RU2008126949A (ru) | 2010-01-10 |
| AR057961A1 (es) | 2007-12-26 |
| CA2631066A1 (en) | 2007-06-07 |
| US20100216788A1 (en) | 2010-08-26 |
| EP1957495A1 (en) | 2008-08-20 |
| WO2007064045A1 (en) | 2007-06-07 |
| MA30046B1 (fr) | 2008-12-01 |
| KR20080084823A (ko) | 2008-09-19 |
| NO20082870L (no) | 2008-09-01 |
| AU2006319787A1 (en) | 2007-06-07 |
| TW200730527A (en) | 2007-08-16 |
| BRPI0619911A2 (pt) | 2016-08-30 |
| JP2009517333A (ja) | 2009-04-30 |
| CR10057A (es) | 2008-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY29246A1 (es) | Nuevos compuestos | |
| PE20061367A1 (es) | Nuevos derivados del fluoreno y composiciones que los contienen | |
| PE20110222A1 (es) | Inhibidores de dipeptidilpeptidasa iv | |
| ECSP056194A (es) | Derivados de pirazolo-quinazolina, procedimiento para su preparacion y su uso como inhibidores de quinasa | |
| PE20090210A1 (es) | Compuestos derivados de pirazolo pirimidina como inhibidores de jak quinasa | |
| MXPA05013733A (es) | 2-aminobenzotiazoles como agonistas inversos del receptor de cb1. | |
| PE20141700A1 (es) | Compuestos de 2-(2,4,5-anilino sustituido) pirimidina | |
| PE20071089A1 (es) | Compuesto heterociclico fusionado como inhibidor de tirosina quinasa | |
| UY30298A1 (es) | Inhibidores de la quinasa c-fms ii | |
| PE20090694A1 (es) | Compuestos moduladores de sirtuinas | |
| CR8505A (es) | Derivados de (3-oxo-3,4-dihidroquinoxalin-2-il-amino)-benzamida y compuesto relacionado, como inhibidores de glucogeno fosforilasa para el tratamiento de la diabetes y obesidad | |
| PE20151249A1 (es) | Derivados de pirazolopirimidina como inhibidores de jak quinasas | |
| PE20091243A1 (es) | Compuesto heterociclico fusionado | |
| EA200870376A1 (ru) | Бензотиазолы, обладающие активностью по отношению к h3-рецептору гистамина | |
| BRPI0514371A (pt) | 2, 4 di (aminofenil) pirimidina como inibidores de plk | |
| SE0202463D0 (sv) | Novel compounds | |
| PE20060524A1 (es) | Compuestos heterociclico fusionados como intermediarios en la preparacion de pirrolotriazinas inhibidoras de cinasa | |
| EA200500721A1 (ru) | Пиримидины, ингибирующие chk, pdk и акт, их получение и применение в качестве лекарственных средств | |
| ECSP088598A (es) | Derivados de piridazinona | |
| NO20044995L (no) | Heterosykliske forbindelser | |
| EA200601747A1 (ru) | Три(цикло)замещённые амидные соединения | |
| CL2007000595A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras. | |
| PE20110560A1 (es) | NUEVOS DERIVADOS DE TRIAZOLO[4,3-a]PIRIDINA, SU PROCEDIMIENTO DE PREPARACION, SU APLICACION COMO MEDICAMENTOS, COMPOSICIONES FARMACEUTICAS Y NUEVA UTILIZACION PARTICULARMENTE COMO INHIBIDORES DE MET | |
| BRPI0407841A (pt) | inibidores heterocìclicos de quinase | |
| CL2011003138A1 (es) | N-(protegido- n-(3-metoxi-5-metilpirazon-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil)piridino-3-sulfonamida y su proceso de preparacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |